Affinage · Toxoplasma gondii

NSM

secreted effector protein NSM · UniProt S8EWJ6

Annotated
2026-09-08
4 papers in source corpus 3 papers cited in narrative 3 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

TgNSM is a bradyzoite-stage secreted dense granule effector of Toxoplasma gondii that is exported into the host cell and traffics to the host nucleus, where it manipulates host transcription to sustain the chronic infection niche (PMID:34043960). In the nucleus it co-opts the NCoR/SMRT transcriptional repressor complex to suppress IFN-driven expression of PKR and MLKL, thereby blocking necroptosis and protecting the parasite's intracellular cyst (PMID:34043960). TgNSM additionally functions as one of eight MYR1-dependent effectors that cooperatively activate the non-canonical NF-κB pathway (RelB/p52) in host cells through TRAF3 depletion, NIK stabilization, and p100 processing, an additive network mechanism in which no single effector is solely responsible (PMID:41959509). Beyond these host-manipulation roles, no further mechanistic detail on TgNSM has been characterized in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 3 steps
  1. 2021 High

    Established that TgNSM is a nuclear-targeted secreted effector whose function is to protect the chronic cyst by silencing host necroptosis, answering how the bradyzoite stage evades IFN-driven cell death.

    Evidence Genetic analysis of nucleus-localizing secreted effectors, epistasis with TgIST, and PKR/MLKL expression plus necroptosis assays in infected cells

    PMID:34043960

    Open questions at the time
    • Mechanism by which TgNSM engages NCoR/SMRT (direct binding vs. bridging) not resolved
    • Route of nuclear import and export machinery not defined in this finding
    • Whether IFN-independent targets exist is unaddressed
  2. 2025 Low

    Correlated NSM protein abundance with culture adaptation and virulence factor expression, hinting that NSM levels track the parasite's virulent state but without testing function.

    Evidence Label-free LC-MS proteomics comparing low- and high-passage field isolates

    PMID:41036225

    Open questions at the time
    • Expression-correlation only; no direct mechanistic test of NSM function
    • Causal link between NSM abundance and virulence not established
    • Does not distinguish cause from consequence of adaptation
  3. 2026 Medium

    Placed TgNSM within a redundant network of eight MYR1-dependent effectors that additively activate non-canonical NF-κB, clarifying that NSM's role in this pathway is cooperative rather than singular.

    Evidence Combinatorial knockout parasite panel with RelB/p52 nuclear accumulation assays and Western blots for TRAF3, NIK, and p100/p52 (preprint)

    PMID:41959509

    Open questions at the time
    • Individual contribution of NSM cannot be isolated from the other seven effectors
    • Direct molecular target of NSM in the TRAF3/NIK axis unknown
    • Preprint, not yet peer-reviewed

Open questions

Synthesis pass · forward-looking unresolved questions
  • How TgNSM physically engages the NCoR/SMRT complex and whether its necroptosis-blocking and NF-κB-activating activities are mechanistically linked remains unresolved.
  • No structural or biochemical map of the NSM–NCoR/SMRT interaction
  • No direct molecular target within the non-canonical NF-κB machinery
  • Relationship between the two host-manipulation activities undefined

Mechanism profile

Synthesis pass · controlled-vocabulary classification
Complex memberships
Host NCoR/SMRT transcriptional repressor complex (co-opted by TgNSM)

Evidence

Reading pass · 3 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2021 TgNSM is a bradyzoite-stage secreted effector that localizes to the host cell nucleus and co-opts the NCoR/SMRT transcriptional repressor complex to inhibit IFN-driven expression of PKR and MLKL, thereby blocking necroptosis and protecting the parasite's intracellular cyst niche during chronic infection. Genetic analysis of secreted effectors localizing to the host nucleus; functional epistasis with TgIST; measurement of PKR and MLKL expression; necroptosis assays in infected cells Cell host & microbe High 34043960
2026 TgNSM acts as one of eight MYR1-dependent dense granule effectors that cooperatively activate the non-canonical NF-κB pathway (RelB/p52) in host cells; no single effector is solely responsible, indicating an additive network mechanism. Activation involves TRAF3 depletion, NIK stabilization, p100 phosphorylation, and p52 processing. Combinatorial knockout parasite panel; nuclear accumulation assays for RelB and p52; Western blot for TRAF3, NIK, p100/p52; MYR1-dependent export dependency confirmed genetically bioRxivpreprint Medium 41959509
2025 NSM protein abundance increases during in vitro culture adaptation of T. gondii field isolates, correlating with increased virulence factor expression, as measured by label-free LC-MS proteomics. Label-free liquid chromatography-mass spectrometry proteomics comparing low- and high-passage isolates Frontiers in cellular and infection microbiology Low 41036225

Source papers

Stage 0 corpus · 4 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2021 Toxoplasma gondii secreted effectors co-opt host repressor complexes to inhibit necroptosis. Cell host & microbe 68 34043960
2024 IL-36 Gamma: A Novel Adjuvant Cytokine Enhancing Protective Immunity Induced by DNA Immunization with TGIST and TGNSM Against Toxoplasma gondii Infection in Mice. Microorganisms 8 39597646
2025 Proteome changes during in vitro culture adaptation of Toxoplasma gondii archetypal II and III field isolates. Frontiers in cellular and infection microbiology 1 41036225
2026 A Suite of Eight Toxoplasma gondii Effectors Cooperates to Activate the Non-canonical NF-κB Pathway. bioRxiv : the preprint server for biology 0 41959509